Amanta Healthcare Ltd (AMANTA) is currently trading at 162.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Amanta Healthcare is a Gujarat-headquartered pharmaceutical company that develops, manufactures and markets sterile liquid parenteral products using Aseptic Blow-Fill-Seal (ABFS) and ISBM technologies across LVP and SVP segments, supplying hospital-focused therapies, medical devices and closure systems domestically and to export markets including advanced regulated geographies. SteriPort contributes roughly 44% of revenue and SteriPort Line 3 has received FDA plan approval; Amanta Healthcare expects commercial production by late August 2026 and projects the new line to annualize at about INR120 crores top-line, materially improving capacity and absorption of overheads for higher-margin sterile products. The SVP portfolio contributed about 20% of FY26 revenue and Amanta Healthcare is adding a specialised SVP facility with FAT scheduled in November and commercialization targeted around Q4 FY27, focused on inhalation solutions, ophthalmics and preservative-free unit doses targeted at advanced export markets, with a 20-product development pipeline. Q1 FY27 revenue was INR69 crores (approx +5% YoY) with EBITDA near INR15 crores and EBITDA margin around 22%; management projects operating margin expansion to roughly 25%–26% at peak utilization after SteriPort, SVP commissioning and solar savings, with peak revenue potential near INR425 crores when all capacities are operational. Amanta Healthcare has invested materially in capex: SteriPort Line 3 total capex ~INR90 crores (≈INR80 crores spent), SVP capex ~INR30 crores (≈INR7 crores spent), and incremental annual depreciation of ~INR6 crores; net working capital days remain elevated (~141 days) and reported net debt metrics are improving but still reflect recent capex and solar financing.

Over the past 52 weeks, Amanta Healthcare Ltd has traded between a low of ₹93.10 and a high of ₹210.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Amanta Healthcare Ltd has a market capitalization of approximately 633.70. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Amanta Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 43.17 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 633.70 Cr, Amanta Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Amanta Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Amanta Healthcare Ltd is 43.17. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The IPO was stated as a ₹126 crore book-built issue and entirely a fresh issue, with total issue size shown as 1,00,00,000 shares aggregating up to ₹126 crore.